MAGNOLIA CAPITAL ADVISORS LLC - Immune Therapeutics Inc ownership

Back to all holdings Add to watchlist

Immune Therapeutics Inc's ticker is IMUN and the CUSIP is 45252A107. A total of 3 filers reported holding Immune Therapeutics Inc in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
MAGNOLIA CAPITAL ADVISORS LLC ownership history of Immune Therapeutics Inc
ValueSharesWeighting
Q4 2020$0–23,0000.0%0.00%–
Q3 2020$0
-100.0%
23,0000.0%0.00%
-100.0%
Q2 2020$1,000–23,0000.0%0.00%–
Q1 2020$0–23,0000.0%0.00%–
Q4 2019$0–23,000–0.00%–
 Download
Other shareholders
Immune Therapeutics Inc shareholders Q4 2019
NameSharesValueWeighting ↓
MAI Capital Management 12,500$00.00%
GLENMEDE TRUST CO NA 10,000$00.00%
UMB Bank, n.a. 400,000$3,0000.00%
View complete list of Immune Therapeutics Inc shareholders